DOUGLAS GRISIER: Open Payments
NPI 1043276934 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 23 payments from 9 companies in 2025. Trend: 2023 $754 · 2024 $843 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $316 |
| Exact Sciences Corporation | 8 | $191 |
| Madrigal Pharmaceuticals | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Lilly USA, LLC | 3 | $61 |
| Boston Scientific Corporation | 1 | $27 |
| Alkermes, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REPATHA, Otezla, The Cologuard Plus Collection Kit, REZDIFFRA, BREZTRI, Cologuard Collection Kit, ZEPBOUND, WATCHMAN Access System.
Industry payments across PA — which companies pay providers there.
